comparemela.com

Page 3 - Vor Biopharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vor Biopharma Inc (NYSE:VOR) Receives $15 19 Average PT from Analysts

Vor Biopharma Inc (NYSE:VOR) Receives $15 19 Average PT from Analysts
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Vor Biopharma (NYSE:VOR) Stock Price Down 2 5%

Vor Biopharma (NYSE:VOR) Stock Price Down 2 5%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Institutions own 36% of Vor Biopharma Inc (NASDAQ:VOR) shares but private equity firms control 43% of the company

Key Insights Vor Biopharma's significant private equity firms ownership suggests that the key decisions are influenced.

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Vor Biopharma s (VOR) Outperform Rating Reiterated at Wedbush

Vor Biopharma (NYSE:VOR – Get Free Report)‘s stock had its “outperform” rating reiterated by Wedbush in a report issued on Thursday, Benzinga reports. They presently have a $11.00 price objective on the stock. Wedbush’s target price suggests a potential upside of 378.26% from the company’s previous close. Vor Biopharma Trading Down 0.9 % VOR opened […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.